Shaoyi Sun

760 total citations
19 papers, 448 citations indexed

About

Shaoyi Sun is a scholar working on Organic Chemistry, Molecular Biology and Oncology. According to data from OpenAlex, Shaoyi Sun has authored 19 papers receiving a total of 448 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 10 papers in Molecular Biology and 6 papers in Oncology. Recurrent topics in Shaoyi Sun's work include Synthetic Organic Chemistry Methods (5 papers), Cancer Treatment and Pharmacology (4 papers) and Oxidative Organic Chemistry Reactions (3 papers). Shaoyi Sun is often cited by papers focused on Synthetic Organic Chemistry Methods (5 papers), Cancer Treatment and Pharmacology (4 papers) and Oxidative Organic Chemistry Reactions (3 papers). Shaoyi Sun collaborates with scholars based in China, United States and Canada. Shaoyi Sun's co-authors include Jianmin Fu, Zaihui Zhang, Qi Jia, Derrick L. J. Clive, Charles J. Cohen, Christoph M. Dehnhardt, Junhu Zhang, Michael D. Winther, Sultan Chowdhury and Steven S. Wesolowski and has published in prestigious journals such as Chemical Communications, Journal of Medicinal Chemistry and Tetrahedron Letters.

In The Last Decade

Shaoyi Sun

19 papers receiving 441 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Shaoyi Sun China 11 283 168 46 30 30 19 448
Vincent J. Colandrea United States 11 280 1.0× 147 0.9× 30 0.7× 39 1.3× 16 0.5× 13 459
Yasuhiro Yonetoku Japan 12 200 0.7× 200 1.2× 55 1.2× 30 1.0× 27 0.9× 20 491
Yohei Kiyotsuka Japan 13 293 1.0× 159 0.9× 43 0.9× 28 0.9× 24 0.8× 23 427
Shuji Kitamura Japan 12 204 0.7× 276 1.6× 16 0.3× 23 0.8× 26 0.9× 14 476
Ravi Kurukulasuriya United States 12 240 0.8× 196 1.2× 46 1.0× 28 0.9× 25 0.8× 15 432
Fuk‐Wah Sum United States 11 271 1.0× 214 1.3× 26 0.6× 51 1.7× 25 0.8× 13 485
Michael D. Dowle United Kingdom 9 364 1.3× 177 1.1× 97 2.1× 34 1.1× 22 0.7× 22 530
Bernat Vidal Spain 20 559 2.0× 238 1.4× 67 1.5× 17 0.6× 34 1.1× 39 773
Malken Bayrakdarian Canada 13 239 0.8× 146 0.9× 62 1.3× 47 1.6× 21 0.7× 17 390
Ralf Plate Netherlands 15 291 1.0× 250 1.5× 35 0.8× 61 2.0× 42 1.4× 47 586

Countries citing papers authored by Shaoyi Sun

Since Specialization
Citations

This map shows the geographic impact of Shaoyi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shaoyi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shaoyi Sun more than expected).

Fields of papers citing papers by Shaoyi Sun

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shaoyi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shaoyi Sun. The network helps show where Shaoyi Sun may publish in the future.

Co-authorship network of co-authors of Shaoyi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Shaoyi Sun. A scholar is included among the top collaborators of Shaoyi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shaoyi Sun. Shaoyi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Sun, Shaoyi, et al.. (2025). Research progress on peptides that inhibit melanin synthesis. Frontiers in Pharmacology. 16. 1610623–1610623. 2 indexed citations
2.
Liu, Jun, et al.. (2021). Identification of key enzymes involved in the accumulation of carotenoids during fruit ripening of Lycium barbarum L. by a proteomic approach. International Journal of Food Science & Technology. 56(10). 5050–5061. 3 indexed citations
3.
Sun, Shaoyi, Qi Jia, Sophia Lin, et al.. (2021). Identification of aryl sulfonamides as novel and potent inhibitors of NaV1.5. Bioorganic & Medicinal Chemistry Letters. 45. 128133–128133. 2 indexed citations
4.
Sun, Shaoyi & Steven S. Wesolowski. (2021). Biologically active metabolites in drug discovery. Bioorganic & Medicinal Chemistry Letters. 48. 128255–128255. 10 indexed citations
5.
Sun, Shaoyi, Qi Jia, & Zaihui Zhang. (2019). Applications of amide isosteres in medicinal chemistry. Bioorganic & Medicinal Chemistry Letters. 29(18). 2535–2550. 68 indexed citations
6.
Sun, Shaoyi & Jianmin Fu. (2018). Methyl-containing pharmaceuticals: Methylation in drug design. Bioorganic & Medicinal Chemistry Letters. 28(20). 3283–3289. 117 indexed citations
7.
Sun, Shaoyi, Zaihui Zhang, Sultan Chowdhury, et al.. (2014). Discovery of triazolone derivatives as novel, potent stearoyl-CoA desaturase-1 (SCD1) inhibitors. Bioorganic & Medicinal Chemistry. 23(3). 455–465. 10 indexed citations
8.
Sun, Shaoyi, Qi Jia, Zaihui Zhang, et al.. (2014). The discovery of benzenesulfonamide-based potent and selective inhibitors of voltage-gated sodium channel Nav1.7. Bioorganic & Medicinal Chemistry Letters. 24(18). 4397–4401. 17 indexed citations
9.
Sun, Shaoyi, Charles J. Cohen, & Christoph M. Dehnhardt. (2014). Inhibitors of voltage-gated Sodium Channel Na v 1.7: Patent Applications Since 2010. Pharmaceutical Patent Analyst. 3(5). 509–521. 27 indexed citations
10.
Sun, Shaoyi, Richard A. Dean, Qi Jia, et al.. (2013). Discovery of XEN445: A potent and selective endothelial lipase inhibitor raises plasma HDL-cholesterol concentration in mice. Bioorganic & Medicinal Chemistry. 21(24). 7724–7734. 10 indexed citations
11.
Sun, Shaoyi, Zaihui Zhang, Jia Qi, et al.. (2013). Systematic evaluation of amide bioisosteres leading to the discovery of novel and potent thiazolylimidazolidinone inhibitors of SCD1 for the treatment of metabolic diseases. Bioorganic & Medicinal Chemistry Letters. 24(2). 520–525. 18 indexed citations
12.
Sun, Shaoyi, Zaihui Zhang, Rostam Namdari, et al.. (2013). Discovery of thiazolylpyridinone SCD1 inhibitors with preferential liver distribution and reduced mechanism-based adverse effects. Bioorganic & Medicinal Chemistry Letters. 24(2). 526–531. 9 indexed citations
13.
Zhang, Zaihui, Shaoyi Sun, Shifeng Liu, et al.. (2012). Discovery of Piperazin-1-ylpyridazine-Based Potent and Selective Stearoyl-CoA Desaturase-1 Inhibitors for the Treatment of Obesity and Metabolic Syndrome. Journal of Medicinal Chemistry. 56(2). 568–583. 27 indexed citations
14.
Filipski, Kevin J., Jeffrey T. Kohrt, Agustin Casimiro‐Garcia, et al.. (2006). A versatile copper-catalyzed coupling reaction of pyridin-2(1H)-ones with aryl halides. Tetrahedron Letters. 47(44). 7677–7680. 47 indexed citations
15.
Clive, Derrick L. J., et al.. (2003). Synthetic studies related to CP-225,917. Canadian Journal of Chemistry. 81(7). 811–824. 4 indexed citations
16.
Clive, Derrick L. J. & Shaoyi Sun. (2001). Synthesis of the racemic tetracyclic core of CP-225,917—a model compound lacking the sidearms of the natural product. Tetrahedron Letters. 42(36). 6267–6270. 15 indexed citations
17.
Clive, Derrick L. J., et al.. (2000). An approach to the anhydride unit of CP-225,917 and CP-263,114. Tetrahedron Letters. 41(33). 6259–6263. 12 indexed citations
18.
Clive, Derrick L. J., Yong Tao, Yunxin Bo, et al.. (2000). Synthetic studies on calicheamicin γ1I—synthesis of(−)-calicheamicinone and models representing the four sugars and the aromatic system. Chemical Communications. 1341–1350. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026